NL163213C - Werkwijze voor de bereiding van preparaten met anti- bacteriele werking, die als werkzame verbinding een gesubstitueerd benzyldiaminopyrimidine bevatten, en werkwijze voor de bereiding van de werkzame verbinding. - Google Patents

Werkwijze voor de bereiding van preparaten met anti- bacteriele werking, die als werkzame verbinding een gesubstitueerd benzyldiaminopyrimidine bevatten, en werkwijze voor de bereiding van de werkzame verbinding.

Info

Publication number
NL163213C
NL163213C NL6514743.A NL6514743A NL163213C NL 163213 C NL163213 C NL 163213C NL 6514743 A NL6514743 A NL 6514743A NL 163213 C NL163213 C NL 163213C
Authority
NL
Netherlands
Prior art keywords
preparation
active compound
diaminopyrimidine
preparations
substituted benzyl
Prior art date
Application number
NL6514743.A
Other languages
English (en)
Other versions
NL6514743A (nl
NL163213B (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27559952&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL163213(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL6514743A publication Critical patent/NL6514743A/xx
Publication of NL163213B publication Critical patent/NL163213B/nl
Application granted granted Critical
Publication of NL163213C publication Critical patent/NL163213C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
NL6514743.A 1964-11-12 1965-11-12 Werkwijze voor de bereiding van preparaten met anti- bacteriele werking, die als werkzame verbinding een gesubstitueerd benzyldiaminopyrimidine bevatten, en werkwijze voor de bereiding van de werkzame verbinding. NL163213C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US41071064A 1964-11-12 1964-11-12
US41079364A 1964-11-12 1964-11-12
US45416865A 1965-05-07 1965-05-07
US45417265A 1965-05-07 1965-05-07
US46083465A 1965-06-02 1965-06-02
US470917A US3341541A (en) 1964-11-12 1965-07-09 Processes and intermediates for pyrimidine derivatives

Publications (3)

Publication Number Publication Date
NL6514743A NL6514743A (nl) 1966-05-13
NL163213B NL163213B (nl) 1980-03-17
NL163213C true NL163213C (nl) 1980-08-15

Family

ID=27559952

Family Applications (3)

Application Number Title Priority Date Filing Date
NL6514178A NL6514178A (nl) 1964-11-12 1965-11-02
NL6514472A NL6514472A (nl) 1964-11-12 1965-11-08
NL6514743.A NL163213C (nl) 1964-11-12 1965-11-12 Werkwijze voor de bereiding van preparaten met anti- bacteriele werking, die als werkzame verbinding een gesubstitueerd benzyldiaminopyrimidine bevatten, en werkwijze voor de bereiding van de werkzame verbinding.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NL6514178A NL6514178A (nl) 1964-11-12 1965-11-02
NL6514472A NL6514472A (nl) 1964-11-12 1965-11-08

Country Status (15)

Country Link
US (3) US3485840A (nl)
BE (3) BE671981A (nl)
BR (3) BR6574670D0 (nl)
CH (2) CH467784A (nl)
DE (2) DE1545966A1 (nl)
DK (2) DK125553B (nl)
FI (1) FI43251B (nl)
FR (1) FR5411M (nl)
GB (7) GB1132084A (nl)
IL (7) IL24497A (nl)
IT (1) IT1058251B (nl)
MY (2) MY6700159A (nl)
NL (3) NL6514178A (nl)
NO (2) NO119948B (nl)
SE (4) SE326185B (nl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis
US3515783A (en) * 1967-10-20 1970-06-02 Hoffmann La Roche Antibacterial composition containing 5-methyl - 3 - sulfanilamidoisoxazole and trimethoxybenzyl pyrimidine
DE2065367C2 (de) * 1969-03-06 1985-04-04 The Wellcome Foundation Ltd., London Verfahren zur Herstellung von 2,4- Diamino-5-benzylpyrimidinen
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles
CH513181A (de) * 1969-06-12 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung von N-Oxyden von Benzylpyrimidinen
US3996356A (en) * 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
US3692787A (en) * 1970-02-16 1972-09-19 Burroughs Wellcome Co Substituted 2,4-diamino-5-benzyl pyrimidines
US3684810A (en) * 1970-03-11 1972-08-15 Hoffmann La Roche Process for 2,4-diamino-5-(3,5-dimethoxy-4-hydroxybenzyl) pyrimidine
US3993761A (en) * 1971-12-01 1976-11-23 Hoffmann-La Roche Inc. Antibacterial compositions
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
BE795023A (fr) * 1972-02-07 1973-08-06 Hoffmann La Roche Nouvelles benzylpyrimidines
IT1044231B (it) * 1972-03-16 1980-03-20 Hoffmann La Roche Combinazione di sostanze attive utile per combattere infezioni da batteri gram positivi e gran negativi
DE2342213C3 (de) * 1972-10-12 1979-10-18 F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) Verwendung von potenzierten SuIf onamiden bei der Behandlung oder Verhinderung von Fischinfektionen
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
US4143227A (en) * 1973-02-26 1979-03-06 Hoffmann-La Roche Inc. Process for substituted 5-benzyl-2,4-diamino-pyrimidines
US3931181A (en) * 1973-07-27 1976-01-06 Hoffmann-La Roche Inc. 2,4-Diamino-5-benzylpyrimidines
CH591456A5 (nl) * 1973-09-12 1977-09-15 Hoffmann La Roche
US4076810A (en) * 1973-11-08 1978-02-28 Hoffmann-La Roche Inc. Benzylpyrimidine antibacterial composition
DK136470B (da) * 1973-11-08 1977-10-17 Hoffmann La Roche Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf.
CH591457A5 (nl) * 1973-11-08 1977-09-15 Hoffmann La Roche
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
NL7609171A (nl) * 1975-08-29 1977-03-02 Hoffmann La Roche Werkwijze voor het bereiden van antibacte- riele middelen.
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2635765C3 (de) * 1976-08-09 1979-02-08 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von 2,4-EMamino-5-(3',4'r5'-trimethoxybenzyl)-pyrimidin
LU77364A1 (nl) * 1977-05-18 1979-01-19
JPS55102517A (en) * 1979-01-30 1980-08-05 Shionogi & Co Ltd Preparation of sulfamethoxazole-trimethoprim complex for administration via body cavity
DE2944145A1 (de) * 1979-11-02 1981-05-14 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von 2,4-diaminopyrimidin
JPS57109713A (en) * 1980-12-26 1982-07-08 Shionogi & Co Ltd Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom
IT1138146B (it) * 1981-08-11 1986-09-17 Proter Spa Processo per la produzione della 2,4-diammino-(3,5-dimetossi-4-metos sietossi-benzil)-pirimidina
FI64427C (fi) * 1982-05-13 1989-11-08 Uponor Nv Lattiakaivo tai muu kuppimainen vesilukko.
HU197670B (en) * 1986-02-28 1989-05-29 Egyt Gyogyszervegyeszeti Gyar Process for producing composition comprising 2,4-diamino-5-(3,4-dimethoxybenzyl)-pyrimidine or pharmaceutically suitable acid addition salt thereof as active ingredient
FR2595697B1 (fr) * 1986-03-13 1988-07-08 Rousselot Cie Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
US4857651A (en) * 1987-07-29 1989-08-15 American Cyanamid Company α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof
US4996198A (en) * 1988-07-11 1991-02-26 Hoffmann-La Roche Inc. Anticoccidial composition
US5135924A (en) * 1989-01-03 1992-08-04 Hoffmann-La Roche Inc. Therapeutic treatment of animals with oral administration of ormetoprim-potentiated sulfonamides
US5158979A (en) * 1989-04-19 1992-10-27 New York University Method and compositions for treating pneumocystic carini infections
US5258373A (en) * 1991-07-17 1993-11-02 Hoffmann-La Roche Inc. Anticoccidial compositions
DE4333688C2 (de) * 1993-10-02 2003-11-06 Guenter Ege Verfahren zur Herstellung von 3-Aryl-2-(dialkoxymethyl)-propannitrilen und ihre Umsetzung zu 5-Arylmethyl-2,4-diamino-pyrimidinen, insbesondere zu Trimethoprim
US5514681A (en) * 1994-08-17 1996-05-07 Virginia Tech Intellectual Properties, Inc. Compositions and methods for controlling pest insects
TW438796B (en) * 1996-05-15 2001-06-07 Hoffmann La Roche 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same
US20090162858A1 (en) * 2007-09-18 2009-06-25 Cornish Virginia W Orthogonal chemical inducer of dimerization
MY146947A (en) * 2007-10-29 2012-10-15 Nippon Suisan Kaisha Ltd Antiparasitic agent for fish and method of controlling proliferation of fish parasites
TWI429397B (zh) * 2009-04-27 2014-03-11 Nippon Suisan Kaisha Ltd 含有葉酸合成抑制劑及/或葉酸活性化抑制劑之組成物的用途
FR3049861A1 (fr) 2016-04-07 2017-10-13 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe
CN106083653A (zh) * 2016-06-06 2016-11-09 江苏天和制药有限公司 奥美普林中间体肉桂腈的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628236A (en) * 1953-02-10 S-benzyl
US3049544A (en) * 1962-08-14 Method for the preparation of
US2658897A (en) * 1951-06-27 1953-11-10 Burroughs Wellcome Co 2, 4-diamino-5-benzyl pyrimidines
GB734801A (en) * 1953-03-06 1955-08-10 Wellcome Found Improvements in and relating to derivatives of pyrimidine and the manufacture thereof
US2783178A (en) * 1954-06-22 1957-02-26 American Scient Lab Inc Stable concentrated sulfaquinoxaline solutions and method for preparing
US2823160A (en) * 1955-03-29 1958-02-11 Whitmoyer Lab Inc Substituted pyrimidines compositions for chemotherapy of coccidiosis
US2909522A (en) * 1957-02-21 1959-10-20 Burroughs Wellcome Co Trialkoxybenzylpyrimidines and method
DE1303727B (de) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3085937A (en) * 1960-11-21 1963-04-16 Shionogi & Co Method of combating coccidiosis with sulfonamide compositions
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
GB1132085A (en) 1968-10-30
US3341541A (en) 1967-09-12
FR5411M (nl) 1967-10-02
CH467270A (de) 1969-01-15
SE326185B (nl) 1970-07-20
IL24497A (en) 1969-11-12
FI43251B (nl) 1970-11-02
GB1132083A (en) 1968-10-30
BR6574670D0 (pt) 1973-08-07
SE327122B (nl) 1970-08-10
IL32696A (en) 1969-12-31
NL6514743A (nl) 1966-05-13
SE311160B (nl) 1969-06-02
NL163213B (nl) 1980-03-17
DE1545966A1 (de) 1970-02-26
NL6514472A (nl) 1966-05-13
BR6574668D0 (pt) 1973-08-07
GB1132082A (en) 1968-10-30
IT1058251B (it) 1982-04-10
GB1133766A (en) 1968-11-20
DE1545967A1 (de) 1969-11-20
BE671983A (nl) 1966-05-09
BR6574667D0 (pt) 1973-08-16
MY7200071A (en) 1972-12-31
SE346314B (nl) 1972-07-03
GB1132086A (en) 1968-10-30
US3461206A (en) 1969-08-12
DK125553B (da) 1973-03-05
GB1132084A (en) 1968-10-30
IL24498A (en) 1969-07-30
DK115847B (da) 1969-11-17
CH467784A (de) 1969-01-31
NO119948B (nl) 1970-08-03
NL6514178A (nl) 1966-05-13
BE671982A (nl) 1966-05-09
DE1545967B2 (de) 1974-05-16
IL32697A (en) 1969-12-31
IL32694A (en) 1969-12-31
NO115741B (nl) 1968-11-25
IL24534A (en) 1969-12-31
US3485840A (en) 1969-12-23
GB1062508A (en) 1967-03-22
MY6700159A (en) 1967-12-31
IL32695A (en) 1969-12-31
DE1545967C3 (de) 1974-12-19
BE671981A (nl) 1966-05-09

Similar Documents

Publication Publication Date Title
NL163213C (nl) Werkwijze voor de bereiding van preparaten met anti- bacteriele werking, die als werkzame verbinding een gesubstitueerd benzyldiaminopyrimidine bevatten, en werkwijze voor de bereiding van de werkzame verbinding.
NL160150C (nl) Werkwijze ter bereiding van 3-acyloxy-2-fenyl-1h- -indeen-1-on-derivaten met herbicide- en acaricide werking, alsmede herbicide- en acaricidepreparaten die deze verbindingen als actieve component bevatten.
NL148889B (nl) Werkwijze voor de bereiding van tegen patogene protozoen actieve preparaten, alsmede voor de bereiding van daarvoor geschikte 1-(2-hydroxyalkyl)-5-nitroimidazolen.
NL148605B (nl) Werkwijze voor het bereiden van pesticide carbamaten, alsmede werkwijze voor het bereiden van pesticide preparaten.
NL154517B (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat werkzaam als hematicum en een werkwijze voor de bereiding van een als zodanig werkzame verbinding.
NL139522B (nl) Werkwijze ter bereiding van 0-fenylcarbamaten met herbicide werking, alsmede van herbicide preparaten, welke deze verbindingen als actieve bestanddelen bevatten.
NL149179B (nl) Werkwijze voor het bereiden van een alfa-gefosforforyleerde oximinoverbinding met insekticide, acaricide of vermicide werking en werkwijze ter bereiding van preparaten voor het bestrijden van schadelijke organismen, en gevormde preparaten.
NL167963C (nl) Werkwijze voor de bereiding van onkruid verdelgende preparaten, die thiadiazolylureumverbindingen bevatten, en werkwijze voor de bereiding van dergelijke thiadiazolylureumverbindingen.
NL145853B (nl) Werkwijze ter bereiding van 1-acylindool-derivaten en van therapeutische preparaten, die de aldus verkregen verbindingen als werkzaam bestanddeel bevatten.
NL148915B (nl) Werkwijze voor de bereiding van poly-epsilon-caprolactam.
NL155547B (nl) Werkwijze voor het bereiden van 1,2,4-thiadiazolylurea en van herbicide preparaten, die deze verbindingen als werkzaam bestanddeel bevatten.
NL140843B (nl) Werkwijze voor de bereiding van op het zenuwstelsel werkzame preparaten.
NL160550C (nl) Werkwijze ter bereiding van insekticide en acaricide pre- paraten, gevormde preparaten en werkwijze ter bereiding van verbindingen met insekticide en acaricide werking.
NL148904B (nl) Werkwijze ter bereiding van 3-oxo-5554,9,11-19-nor-androstatrienen met anabole en androgene werking, werkwijze ter bereiding van farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen.
NL142950B (nl) Werkwijze voor de bereiding van een 1-aryloxy-2-hydroxy-3-isopropylaminopropaanderivaat en zouten daarvan, alsmede voor de bereiding van (beta)-adrenolytisch werkzame farmaceutische preparaten die deze verbinding als actief bestanddeel bevatten.
NL175874C (nl) Werkwijze voor de bereiding van vloeibare samenstellingen met rodenticide werking, alsmede ter bereiding van preparaten, die deze vloeibare samenstellingen als werkzame stof bevatten.
NL139454B (nl) Werkwijze voor de bereiding van verbindingen, die een anti-ontstekingswerkzaamheid bezitten, alsmede van preparaten met anti-ontstekingswerkzaamheid, die deze verbindingen als werkzame stof bevatten.
NL152254B (nl) Werkwijze ter bereiding van middelen ter bestrijding van schadelijke organismen, welke middelen een formamidine bevatten, alsmede werkwijze ter bereiding van een formamidine.
NL143895B (nl) Werkwijze voor de bereiding van een reukstofcompositie en werkwijze ter bereiding van een werkzame verbinding ten gebruike daarbij.
NL145862B (nl) Werkwijze voor de bereiding van 0,0-dialkyl-0 (4-alkylmercapto-halogeenfenyl) thiofosfaten met insekticide en/of acaricide werking alsmede van preparaten, welke deze verbindingen bevatten.
NL141177B (nl) Werkwijze voor de bereiding van herbicide werkzame amidofenylcarbamaten.
NL7505220A (nl) Cyanoureumverbinding met biocide werking alsmede preparaten die deze verbinding als actieve com- ponent bevatten.
NL142592B (nl) Werkwijze voor het bereiden van amidinen of daarvan afgeleide zuur-additiezouten, die werkzaam zijn als antagonisten van 5-hydroxytryptamine, en van farmaceutische preparaten, die ten minste een van deze verbindingen als werkzame verbinding bevatten.
NL142052B (nl) Werkwijze voor de bereiding van fungicide preparaten.
NL149501B (nl) Werkwijze ter bereiding van een verbinding met insekticide en/of acaricide activiteit, van een insekticide en/of acaricide preparaat alsmede het gevormde insekticide en/of acaricide preparaat.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent